首页> 美国卫生研究院文献>Journal for Immunotherapy of Cancer >Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

【2h】

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

机译：基线中性白细胞与淋巴细胞比率（NLR）和衍生的NLR可以预测接受nivolumab治疗的晚期黑色素瘤患者的整体生存率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundPrevious studies have suggested that elevated neutrophil-to-lymphocyte ratio (NLR) is prognostic for worse outcomes in patients with a variety of solid cancers, including those treated with immune checkpoint inhibitors.

机译：背景先前的研究表明，嗜中性粒细胞与淋巴细胞之比（NLR）升高可预示多种实体癌患者（包括接受免疫检查点抑制剂治疗的患者）的预后较差。

著录项

期刊名称 Journal for Immunotherapy of Cancer
作者
Mariaelena Capone; Diana Giannarelli; Domenico Mallardo; Gabriele Madonna; Lucia Festino; Antonio Maria Grimaldi; Vito Vanella; Ester Simeone; Miriam Paone; Giuseppe Palmieri; Ernesta Cavalcanti; Corrado Caracò; Paolo Antonio Ascierto;
展开▼
作者单位

展开▼
年(卷),期 2018(6),-1
年度 2018
页码 74
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
PD-1 inhibitor Nivolumab Biomarkers Neutrophil-to-lymphocyte ratio;

机译：PD-1抑制剂;Nivolumab;生物标志物;中性粒细胞与淋巴细胞的比率;

相似文献

外文文献
中文文献
专利

1. Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab [J] . Ueda Tsutomu, Chikuie Nobuyuki, Takumida Masaya, Acta Oto-Laryngologica . 2020,第1a2期

机译：基线中性粒细胞到淋巴细胞比（NLR）与经复制或转移性头部和颈部癌症患者的临床结果相关，治疗Nivolumab
2. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab [J] . Diem Stefan, Schmid Sabine, Krapf Mirjam, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：中性粒细胞到淋巴细胞比（NLR）和血小板到淋巴细胞比（PLR）作为用Nivolumab处理的非小细胞肺癌（NSCLC）患者的预后标志物
3. Pre-treatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Survival in Patients with Malignant Adrenal Lesions treated with Stereotactic Body Radiotherapy (SBRT) [J] . Mills M., Reddy A. V., Richardson L., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：预治疗中性粒细胞到淋巴细胞比率（NLR）预测患有立体定向体放射治疗（SBRT）的恶性肾上腺病变患者的存活
4. Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT [C] . Sang Ho Lee, Koichi Hayano, Dushyant V. Sahani, International conference on medical image computing and computer-assisted intervention;International workshop on abdominal imaging: computational and clinical applications . 2014

机译：动力学纹理生物标志物通过基线首过灌注CT预测抗血管生成治疗后晚期肝细胞癌患者的生存率
5. Associating Computed Tomography (CT) Imaging Response Criteria and Texture Analysis Measurements with Survival in Patients with Metastatic Melanoma Treated with Anti-angiogenic Therapy. [D] . Gray, Mark Russell. 2014

机译：将计算机断层扫描（CT）成像反应标准和纹理分析测量值与接受抗血管生成治疗的转移性黑色素瘤患者的生存率相关联。
6. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy [O] . Hyerim Ha, Ah-Rong Nam, Ju-Hee Bang, 2016

机译：可溶性程序性死亡配体1（sPDL1）和中性白细胞与淋巴细胞之比（NLR）预测接受姑息化疗的晚期胆道癌患者的生存率
7. Pre-treatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Survival in Patients with Malignant Adrenal Lesions treated with Stereotactic Body Radiotherapy (SBRT) [O] . M. Mills, A.V. Reddy, L. Richardson, 2019

机译：预治疗中性粒细胞到淋巴细胞比率（NLR）预测患有立体定向体放射治疗（SBRT）的恶性肾上腺病变患者的存活

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

摘要

著录项

相似文献

相关主题

期刊订阅